Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Guideline for disinfection and sterilization in healthcare facilities, 2008
2008 Standout
Transcriptional Regulation by Nrf2
2017 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Effects of short-term cortisol infusion on growth hormone-releasing hormone stimulation of growth hormone release in sheep
1995
Glucocorticoid-Induced Osteoporosis: Summary of a Workshop
2001
NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
2009 Standout
EXERCISE AND DIABETES
2001
Acromegaly
2006 Standout
Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications
2006
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
The epidemiology of urinary tract infection
2010 Standout
Nrf2–Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species
2006 Standout
Galanin counteracts the inhibitory effects of glucocorticoids on growth hormone secretion in the rat
1995
Cushing's syndrome
2015 Standout
Antibiotic policies for short-term catheter bladder drainage in adults
2005
Cholinergic control of growth hormone (GH) responses to GH‐releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback
1993
The role of glucocorticoids in the regulation of growth hormone secretion Mechanisms and clinical significance
1992
Inhibitory effects of galanin on growth hormone (GH) release in cultured GH-secreting adenoma cells: Comparative study with octreotide, GH-releasing hormone, and thyrotropin-releasing hormone
1997
Advanced Glycation End Product-induced Apoptosis and Overexpression of Vascular Endothelial Growth Factor and Monocyte Chemoattractant Protein-1 in Human-cultured Mesangial Cells
2002
Pyridostigmine-mediated growth hormone release: evidence for somatostatin involvement.
1992
Short term pirenzepine treatment is ineffective in suppressing 24-h growth hormone secretion in type 1 diabetes mellitus
1993
Glucocorticoid-induced Osteoporosis
2000
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus
2011
Adrenergic and cholinergic involvement in basal and growth hormone-releasing hormone-stimulated growth hormone secretion in glucocorticoid-treated rats
1995
Maturation of the Regulation of Growth Hormone Secretion in Young Males with Hypogonadotropic Hypogonadism Pharmacologically Exposed to Progressive Increments in Serum Testosterone1
1997
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Effects of pyridostigmine on spontaneous and growth hormone‐releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation
1991
Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone.
1995
Effect of pyridostigmine on the growth hormone response to growth hormone-releasing hormone in lean and obese type II diabetic patients
1994
Sickle-cell disease
2010 Standout
Subclinical hyperthyroidism and the risk of cardiovascular events and all-cause mortality: an updated meta-analysis of cohort studies
2012
Effect of glucocorticoids on the paradoxical growth hormone response to thyrotropin-releasing hormone in patients with acromegaly
1995
Role of galanin in the regulation of somatotrope and gonadotrope function in young ovulatory women
1995
Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α
2006 Standout
Suppression of Rat Thromboxane Synthase Gene Transcription by Peroxisome Proliferator-activated Receptor γ in Macrophages via an Interaction with NRF2
2000
Effect of GHRP-6 and ghrh on gh secretion in rats following chronic glucocorticoid treatment
1995
Glucocorticoids and the Genesis of Depressive Illness a Psychobiological Model
1994
Ghrelin: Structure and Function
2005 Standout
Growth hormone neuroregulation in diabetes mellitus
1994
Urinary Tract Infection Syndromes
2013 Standout
Prevalence and Pathologic Features of Sickle Cell Nephropathy and Response to Inhibition of Angiotensin-Converting Enzyme
1992
Effect of two β2-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis
1995
Hypothalamic control of growth hormone (GH) secretion in type i diabetic men: Effect of the combined administration of gh-releasing hormone and hexarelin, a novel GHRP-6 analog.
1996
Lisinopril reduces albuminuria during exercise in low grade microalbuminuric Type 1 diabetic patients: a double blind randomized study
2001
Adrenocorticotropin- and Cortisol-Releasing Effect of Hexarelin, a Synthetic Growth Hormone-Releasing Peptide, in Normal Subjects and Patients with Cushing’s Syndrome1
1997
Dexamethasone Treatment in Man Induces Changes in 24-Hour Growth Hormone (GH) Secretion Profile without Altering Total GH Released*
1991
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons.
1993
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Effects of sex and age on the growth hormone response to galanin in healthy human subjects.
1993
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly.
1995
Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease
2012
Mammalian Sirtuins: Biological Insights and Disease Relevance
2010 Standout
Fasting as a metabolic stress paradigm selectively amplifies cortisol secretory burst mass and delays the time of maximal nyctohemeral cortisol concentrations in healthy men.
1996
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
2010 Standout
Increase in Activity During Calorie Restriction Requires Sirt1
2005 Science
Increased Prevalence of Radiological Spinal Deformities in Active Acromegaly: A Cross-Sectional Study in Postmenopausal Women
2005
Subjective well-being: Three decades of progress.
1999 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
Baclofen-induced growth hormone release in major depression: relationship to dexamethasone suppression test result
1993
Physiological role of galanin in the regulation of anterior pituitary function in humans
1994
Mechanisms of Diabetic Complications
2013 Standout
Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
2013 Standout
Guidelines for the management of thyroid cancer
2014 Standout
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
2016 Standout
The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
2008 Standout
Divergent effects of short term glucocorticoid excess on the gonadotropic and somatotropic axes in normal men.
1992
Neuroendocrine Control of Growth Hormone Secretion
1999
Works of Simonetta Bossoni being referenced
Effect of galanin on growth hormone-releasing hormone-stimulated growth hormone secretion in adult patients with nonendocrine diseases on long-term daily glucocorticoid treatment
1992
Effect of the combined administration of galanin and clonidine on serum growth hormone levels in normal subjects and in patients under chronic glucocorticoid treatment
1994
Growth hormone treatment in aging: state of the art and perspectives
1997
Effect of Galanin on the Growth Hormone (GH) Response to Ghreleasing Hormone in Patients with Cushing's Disease
1993
Effects of Short-Term Glucocorticoid Deprivation on Growth Hormone (GH) Response to GH-Releasing Hormone in Man
1989
Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects
1990
Effects of exogenous growth hormone pretreatment on the pituitary growth hormone response to growth hormone-releasing hormone alone or in combination with pyridostigmine in Type I diabetic patients
1991
Growth Hormone (GH) Responses to GH-Releasing Hormone Alone or Combined with Arginine in Patients with Adrenal Incidentaloma: Evidence for Enhanced Somatostatinergic Tone
2000
Glutamate decarboxylase autoimmunity and growth hormone secretion in type I diabetes mellitus
1997
Arginine blocks the inhibitory effect of hydrocortisone on circulating growth hormone levels in patients with acromegaly
1993
Impaired Growth Hormone (GH) Response to Pyridostigmine in Type 1 Diabetic Patients with Exaggerated GH-Releasing Hormone-Stimulated GH Secretion*
1990
The role of cholinergic tone in modulating the growth hormone response to growth hormone-releasing hormone in normal man
1991
Pyridostigmine Enhances Even if it Does Not Normalize the Growth Hormone Responses to Growth Hormone-Releasing Hormone in Patients with Cushing’s Disease
1991
Variability in the growth hormone response to growth hormone-releasing hormone alone or combined with pyridostigmine in type 1 diabetic patients
1993
EFFECTS OF CALCITONIN ON GH RESPONSE TO PYRIDOSTIGMINE IN COMBINATION WITH hGHRH (1–29) NH2 IN NORMAL ADULT SUBJECTS
1990
Exercise-induced microalbuminuria in patients with active acromegaly: Acute effects of slow-release lanreotide, a long-acting somatostatin analog
2000
Effect of Pretreatment with Pyridostigmine on the Thyrotropin Response to Thyrotropin-Releasing Hormone in Patients with Cushing's Disease
1992
Central Alpha-2 Adrenergic Function in Patients with Essential Hypertension
1990
Pyridostigmine Blocks the Inhibitory Effect of Glucocorticoids on Growth Hormone-Releasing Hormone Stimulated Growth Hormone Secretion in Normal Man
1990
Galanin does not affect the growth hormone-releasing hormone-stimulated growth hormone secretion in patients with hyperthyroidism
1992
Reciprocal relationship between the level of circulating cortisol and growth hormone secretion in response to growth hormone-releasing hormone in man: studies in patients with adrenal insufficiency.
1994
Growth Hormone in Glucocorticoid-Induced Osteoporosis
2002
Picotamide, a Dual TXB Synthetase Inhibitor and TXB Receptor Antagonist, Reduces Exercise-Induced Albuminuria in Microalbuminuric Patients With NIDDM
1993
The negative role of subclinical thyrotoxicosis on the outcome of hospitalized geriatric patients.
2002
Short-Term Administration of Captopril and Nifedipine and Exercise-Induced Albuminuria in Normotensive Diabetic Patients With Early-Stage Nephropathy
1990
Long-term treatment with the dual antithromboxane agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patients.
1998
Arginine normalizes the growth hormone (GH) response to GH-releasing hormone in adult patients receiving chronic daily immunosuppressive glucocorticoid therapy.
1992
A Single Dose of Aztreonam in the Prevention of Urinary Tract Infections in Elderly Catheterized Patients
1990
Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy
1990